We assessed the prognostic value of PPARα expression levels using Kaplan–Meier survival analysis and discovered a positive relationship between expression levels and the prognosis of LGG, AG, and GBM patients (Figures 1(b)–1(d)). The gene discussed is PPARA; the disease is glioblastoma.